FOLEY HOAG LLP

FOLEY HOAG LLP filed a Q1 termination amendment for AMYLYX PHARMACEUTICALS, INC. on September 22, 2025, reporting no lobbying activity.

Lobbying for AMYLYX PHARMACEUTICALS, INC. · pharmaceutical company

Filing · LD-2 quarterly report Q1 termination amendmentNo activity

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Sep 22, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Representation ended

Mar 31, 2025

The registrant reported terminating its work for this client.

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.